This Government Contract opportunity from Department Of Health And Human Services was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Intent to Sole Source - Biolegend Oliogos
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Clinical Center (NIH-CC) has issued a Notice of Intent to negotiate a contract on a sole source basis with Biolegend for the procurement of custom oligonucleotides. These oligonucleotides are required by the PACT team at the Clinical Center Enterprise (CCE) to support single cell copy number analysis using the Tapestri instrument, specifically for CAR-T cell product clinical quality control assays. This acquisition is justified under the statutory authority allowing sole source procurement when only one responsible source exists that can fulfill the agency's needs, as outlined in 41 U.S.C. 253(c)(1) and FAR 6.302-1. This notice clarifies that it is not a request for proposals but invites any other capable suppliers to submit capability statements by May 8, 2026, at 12:00 PM Eastern time for consideration. All submissions received by this deadline will be reviewed, but the government retains full discretion whether or not to proceed with competition. The solicitation number for this acquisition is NOI-CC-OLAO-26-004813, and the contract will be performed in Bethesda, Maryland, under NAICS code 325414. The NIH has indicated no set-aside provisions are being utilized for this procurement.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Biolegend.
Acquisition Description:
Custom Oligios needed by PACT team at CCE to do single cell copy number analysis with Tapestri instrument for CAR-T cell products to support clinical QC assay.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-004813) by 12:00 PM eastern standard time on 05/08/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
